For a change – ethics based regulation that differentiates between the medium and the message.
Dr. Jean Ah Kang, works at DDMAC and is in charge of Web 2.0 policy development. She speaks very well at her interview with Mark Senak, a regulatory affairs lawyer ( eyeonfda.com ). Here is the podcast: FDA’s views and ideas about social media and its use in the life sciences industry.
Blackjack bei Spins of Glory Casino Strategien für österreichische Kartenspieler Table of Contents Die Grundlagen von Blackjack und seine Popularität Die Regeln von Blackjack im
Are you really ready to run a clinical trial? How can you best assess your clinical trial readiness? We work with C-level executives and management
At a site monitoring visit, the CRA works on assuring protocol compliance. Assuring protocol compliance is one of the 3 pillars of GCP: The 3
1 in 7 American adults live alone COVID and social isolation is part of our lives. During COVID, it became easier to recruit patients for
Counterfeiting is old as money itself. Drug counterfeiting is no exception. In this post, we’ll share an analytical approach that you can use to estimate
Is there a “black-box” risk management solution for your clinical trial? What clinical trial risks are the most important for you and your company? Risk
Clinical data made radically simple and affordable.
Copyright © 2022 Flask Data Ltd. All Rights Reserved.
